<qa>  What is the name of the study that is followed by an open-label study?OUTLINE: This is a dose-escalation study of fenretinide 4-HPR Lym-X-SorbTM LXS oral powder, followed by an open-label study. Patients are sequentially assigned to 1 of 2 intervention groups. 